IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of huma

[1]  A. Mouraux,et al.  The N13 spinal component of somatosensory evoked potentials is modulated by heterotopic noxious conditioning stimulation suggesting an involvement of spinal wide dynamic range neurons , 2021, Neurophysiologie Clinique.

[2]  A. Mouraux,et al.  How different experimental models of secondary hyperalgesia change the nociceptive flexion reflex , 2021, Clinical Neurophysiology.

[3]  A. Mouraux,et al.  IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG) , 2021, Trials.

[4]  A. Mouraux,et al.  Human surrogate models of central sensitization: A critical review and practical guide , 2021, European journal of pain.

[5]  S. Dib-Hajj,et al.  Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial , 2019, Brain : a journal of neurology.

[6]  J. Schüttler,et al.  Pain relief in a neuropathy patient by lacosamide: Proof of principle of clinical translation from patient-specific iPS cell-derived nociceptors , 2018, EBioMedicine.

[7]  Andrew S.C. Rice,et al.  Pain and the global burden of disease , 2016, Pain.

[8]  A. Filipe,et al.  Single-Dose, Randomized, Open-Label, Two-Way, Crossover Bioequivalence Study of Two Formulations of Pregabalin 300 mg Hard Capsules in Healthy Volunteers Under Fasting Conditions , 2015, Drugs in R&D.

[9]  A. Płotka,et al.  Pharmacokinetics of Pregabalin Controlled-Release in Healthy Volunteers: Effect of Food in Five Single-Dose, Randomized, Clinical Pharmacology Studies , 2014, Clinical Drug Investigation.

[10]  A. Vinik,et al.  A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy , 2014, Diabetes Care.

[11]  W. Cawello,et al.  Tolerability, pharmacokinetics, and bioequivalence of the tablet and syrup formulations of lacosamide in plasma, saliva, and urine: Saliva as a surrogate of pharmacokinetics in the central compartment , 2013, Epilepsia.

[12]  W. Cawello,et al.  Bioequivalence of Intravenous and Oral Formulations of the Antiepileptic Drug Lacosamide , 2012, Pharmacology.

[13]  R. Treede,et al.  Analysis of hyperalgesia time courses in humans after painful electrical high-frequency stimulation identifies a possible transition from early to late LTP-like pain plasticity , 2011, PAIN®.

[14]  S. Schwartz,et al.  Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial , 2010, Current medical research and opinion.

[15]  G. McCleane.  Lacosamide for pain , 2010, Expert opinion on investigational drugs.

[16]  B. Corrigan,et al.  Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers , 2010, Journal of clinical pharmacology.

[17]  D. Ziegler,et al.  Efficacy and Safety of Lacosamide in Painful Diabetic Neuropathy , 2010, Diabetes Care.

[18]  Stefan Knecht,et al.  Pain sensitivity can be assessed by self-rating: Development and validation of the Pain Sensitivity Questionnaire , 2009, PAIN.

[19]  J. Selam,et al.  Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial. , 2009, The journal of pain : official journal of the American Pain Society.

[20]  S. Bongardt,et al.  Efficacy and Safety of Lacosamide in Diabetic Neuropathic Pain: An 18-week Double-blind Placebo-controlled Trial of Fixed-dose Regimens , 2009, The Clinical journal of pain.

[21]  W. Brannath,et al.  A graphical approach to sequentially rejective multiple test procedures , 2009, Statistics in medicine.

[22]  J. Kroin,et al.  Can a Single Dose of 300 mg of Pregabalin Reach Acute Antihyperalgesic Levels in the Central Nervous System? , 2008, Regional Anesthesia & Pain Medicine.

[23]  Y. Daali,et al.  Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study. , 2007, Clinical therapeutics.

[24]  V. Biton,et al.  Lacosamide in Painful Diabetic Peripheral Neuropathy: A Phase 2 Double-blind Placebo-controlled Study , 2007, The Clinical journal of pain.

[25]  Mariano Serrao,et al.  The lower limb flexion reflex in humans , 2005, Progress in Neurobiology.

[26]  G. Cruccu,et al.  The clinical use of brainstem reflexes and hand-muscle reflexes , 2000, Clinical Neurophysiology.

[27]  F. Mauguière,et al.  The contribution of median nerve SEPs in the functional assessment of the cervical spinal cord in syringomyelia. A study of 24 patients. , 1991, Brain : a journal of neurology.

[28]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[29]  J. Willer.  Studies on pain. Effects of morphine on a spinal nociceptive flexion reflex and related pain sensation in man , 1985, Brain Research.

[30]  J. Kimura,et al.  Disorder of interneurons in Parkinsonism. The orbicularis oculi reflex to paired stimuli. , 1973, Brain : a journal of neurology.

[31]  J. Sandkühler,et al.  Perceptual Correlates of Nociceptive Long-term Potentiation and Long-term Depression in Humans , 2003 .

[32]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[33]  Scott R. Bishop,et al.  The Pain Catastrophizing Scale: Development and validation. , 1995 .

[34]  M. Johnston,et al.  Measures in Health Psychology: A User's Portfolio , 1995 .

[35]  C. Spielberger,et al.  Manual for the State-Trait Anxiety Inventory , 1970 .